Controlled Release Treatment of Depression
Assigneee-Therapeutics Ple
InventorsMalcolm Philip Young, Olusola Clement Idowu, Philip McKeown
Life of this patent
Estimating the term…
Abstract
There is described a pharmaceutical composition for controlled release of an active compound wherein the active compound is selected from the group comprising tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof for the treatment or alleviation of depression. More particularly, there is described an abuse resistant pharmaceutical composition for the treatment of inter alia, depression and controlled release pharmaceutical compositions of related thereto.
Claims29
A pharmaceutical composition for controlled release of an active compound wherein the active compound is selected from the group comprising tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof for the treatment or alleviation of depression.
(canceled)
9-23. (canceled)
A pharmaceutical composition which is abuse resistant comprising an active compound selected from the group comprising tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof for the treatment or alleviation of depression.
(canceled)
(canceled)
35-59. (canceled)
A method of treatment or alleviation of a patient suffering from depression, said method comprising the once daily administration of a therapeutically effective amount of a controlled release composition comprising one or more of the compounds selected from the group consisting of tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine and derivatives and/or combinations thereof.
(canceled)
(canceled)
A method of treatment of a disorder which comprises the administration of a therapeutically effective amount of an abuse resistant form of one or more of the compounds selected from the group consisting of resveratrol, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine and derivatives and/or combinations thereof.
(canceled)
Dependencies are inferred from the claim text.